Researchers aligned with the Nevada State Athletic Commission have found that use of a portable CT scanner can effectively screen professional boxers for intracranial hemorrhage following matches.
Researchers aligned with the Nevada State Athletic Commission have found that use of a portable CT scanner can effectively screen professional boxers for intracranial hemorrhage following matches.
Acute subdural hematoma is the most common injury in boxing and the leading cause of boxing fatalities. Early diagnosis of these intracranial injuries in boxers is associated with better outcomes, said Dr. Albert H. Capanna, a Nevada ringside physician and clinical professor of neurosurgery and pediatrics at the University of Nevada School of Medicine.
While the researchers found no clinical signs or symptoms of injury in any athletes, CT demonstrated in one boxer, who lost by a technical knockout, a 6.2-mm acute subdural hematoma with positive evidence of midline shift of 4.2 mm. Surgical evacuation is indicated in the management of acute subdural hematomas greater than 10 mm in thickness or associated with a midline shift of 5 mm.
The patient was promptly admitted to a nearby hospital, and the subdural hematoma improved over the subsequent two days, including complete resolution of the previous midline shift by discharge on the third day.
The Nevada state legislature has provided funding to the State Athletic Commission to have CT imaging available at athletic venues for immediate use in screening athletes with head injury. However, further studies are needed to risk stratify athletes before including them in long-term screening protocols because of the cumulative radiation dose associated with this practice, Capanna said.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.